BioSpace News Archive

Biotech Beach

Federal Court Rules for Masimo in Suit Against Former Engineer for Unlawful Theft of Company’s Pulse Oximeter Trade Secrets

The United States District Court for the Central District of California has ruled that a former Masimo engineer misappropriated trade secrets related to Masimo’s pulse oximetry technology.

November 17, 2022
·
7 min read
Pharm Country

Upstaza™ Gene Therapy Granted Marketing Authorization for AADC deficiency by UK’s MHRA

PTC Therapeutics, Inc. today announced that Upstaza™ (eladocagene exuparvovec) was granted authorization by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain.

November 17, 2022
·
7 min read
Business

Neuraptive Therapeutics, Inc. Announces Appointment of Leading Industry Executive, Dr. Robert R. Ruffolo as New Director to the Board

Neuraptive Therapeutics, Inc. announced the appointment of industry R&D pioneer Robert (Bob) R. Ruffolo, Jr., Ph.D. to the company’s Board of Directors.

November 17, 2022
·
2 min read
Business

Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow

Kane Biotech Inc. will announce its third quarter 2022 financial results after market close on Thursday, November 24, 2022.

November 17, 2022
·
3 min read
Drug Development

Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma

Agenus (Nasdaq: AGEN), an immuno-oncology company with a broad pipeline targeting cancer and infectious disease, announced expanded data from the Company’s Phase 1 study of botensilimab (Fc-enhanced anti-CTLA-4) and balstilimab (anti-PD-1) in patients with advanced sarcoma.

November 17, 2022
·
6 min read
Pharm Country

IMUNON Announces Strategic Investment in Transomic Technologies

IMUNON, Inc. announced a $375,000 investment in Transomic Technologies, a private company offering a comprehensive array of CRISPR, RNAi and gene expression tools and services.

November 17, 2022
·
6 min read
Pharm Country

SCYNEXIS Applauds the Biomedical Advanced Research and Development Authority (BARDA) for Its New Priority Focus on Investment in Development of Antifungal Treatments to Fight Infections Caused by Drug-Resistant Fungal Threats

BARDA is seeking to support the development of broad-spectrum, oral/IV antifungal drug candidates with novel mechanisms of action that target Candida species, including Candida auris, and Aspergillus species.

November 17, 2022
·
5 min read
Biotech Beach

Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video

Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announces the release of its new animated video for its lead asset in development, LB1148.

November 17, 2022
·
4 min read
Drug Development

ABVC BioPharma Provides Vitargus® Update - Phase II Vitargus® Study Protocol Received Thai FDA Approval

ABVC BioPharma, Inc. today announced that the Vitargus® Phase II Clinical Study Protocol has been approved by the Thailand Food and Drug Administration (FDA).

November 17, 2022
·
3 min read
BioMidwest

Fargo Center for Dermatology Is First in State to Offer Non-Surgical Technology For Treating Common Skin Cancers

SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiotherapy, the most advanced non-surgical technology for the treatment of common skin cancers, announced the availability of the technology in North Dakota.

November 17, 2022
·
3 min read